Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients
- PMID: 22707893
- PMCID: PMC3372805
- DOI: 10.3904/kjim.2012.27.2.203
Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients
Abstract
Background/aims: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are predominantly known as medication-induced diseases. However, at our institution, we have experienced more cases of non-drug-related SJS and TEN than expected. Therefore, we studied the difference between non-drug-related and drug-related SJS and TEN in terms of clinical characteristics and prognoses.
Methods: The etiologies, clinical characteristics, and treatment outcomes for 82 adult patients with SJS and TEN were retrospectively reviewed.
Results: A total of 71 patients (86.6%) were classified as having SJS, and the other 11 patients (13.4%) were classified as having TEN. Drug-related cases were more common (43, 52.4%) than non-drug-related cases (39, 47.6%). Anticonvulsants (12/82, 14.6%) and antibiotics (9/82, 11%) were the most common causative medications. Anemia (p = 0.017) and C-reactive protein of ≥ 5 mg/dL (p = 0.026) were more common in the drug-related cases than in the non-drug-related cases. Intravenous steroid therapy was used as the main treatment regimen (70/82, 85.4%). Of the 82 patients, 8 (9.8%) died during the clinical course. A univariate analysis for mortality showed statistical significance for the following: kidney function abnormality, pneumonia, hemoglobin of < 10 g/dL, and combined underlying diseases. In a multivariate analysis, only pneumonia was statistically significant (odds ratio, 25.79; p = 0.009).
Conclusions: Drugs were the most frequent cause of these diseases. However, non-drug-related causes also contributed to a significant proportion of cases. Physicians should keep this in mind when documenting patient history. In addition, early recognition and treatment may be important for better outcomes.
Keywords: Epidermal necrolysis, toxic; Etiology; Prognosis; Stevens-Johnson syndrome.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30. Burns. 2020. PMID: 31898979
-
Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?Arch Dermatol. 2000 Mar;136(3):323-7. doi: 10.1001/archderm.136.3.323. Arch Dermatol. 2000. PMID: 10724193
-
Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.Australas J Dermatol. 1999 Aug;40(3):131-4. doi: 10.1046/j.1440-0960.1999.00342.x. Australas J Dermatol. 1999. PMID: 10439522
-
Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.J Assoc Physicians India. 2000 Oct;48(10):999-1003. J Assoc Physicians India. 2000. PMID: 11200928 Review.
-
Recent developments in the research of Stevens-Johnson syndrome and toxic epidermal necrolysis: pathogenesis, diagnosis and treatment.Eur J Med Res. 2025 Jun 5;30(1):453. doi: 10.1186/s40001-025-02664-7. Eur J Med Res. 2025. PMID: 40474234 Free PMC article. Review.
Cited by
-
Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital.Dermatol Res Pract. 2018 May 7;2018:3061084. doi: 10.1155/2018/3061084. eCollection 2018. Dermatol Res Pract. 2018. PMID: 29853855 Free PMC article.
-
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.Asia Pac Allergy. 2013 Oct;3(4):215-23. doi: 10.5415/apallergy.2013.3.4.215. Epub 2013 Oct 31. Asia Pac Allergy. 2013. PMID: 24260726 Free PMC article. Review.
-
Viral Infections and Cutaneous Drug-Related Eruptions.Front Pharmacol. 2021 Mar 10;11:586407. doi: 10.3389/fphar.2020.586407. eCollection 2020. Front Pharmacol. 2021. PMID: 33776753 Free PMC article. Review.
-
Stevens-Johnson syndrome following cataract surgery.Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):96-98. doi: 10.1016/j.tjo.2014.05.005. Epub 2014 Jul 28. Taiwan J Ophthalmol. 2015. PMID: 29018676 Free PMC article.
-
Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.CNS Drugs. 2021 Feb;35(2):161-176. doi: 10.1007/s40263-021-00794-0. Epub 2021 Feb 12. CNS Drugs. 2021. PMID: 33580477
References
-
- Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev. 2008;7:598–605. - PubMed
-
- Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7:803–813. - PubMed
-
- Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003;4:561–572. - PubMed
-
- Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019–1024. - PubMed
-
- Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra) J Am Acad Dermatol. 1996;35(5 Pt 1):757–760. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials